Century Therapeutics, Inc. (IPSC)
NASDAQ: IPSC · Real-Time Price · USD
1.900
-0.040 (-2.06%)
At close: Sep 11, 2026, 4:00 PM EDT
1.940
+0.040 (2.11%)
After-hours: Sep 11, 2026, 7:30 PM EDT
Century Therapeutics Market Cap
Century Therapeutics has a market cap or net worth of $351.29 million as of September 11, 2026. Its market cap has increased by 700.93% in one year.
Market Cap
351.29M
Enterprise Value
270.24M
1-Year Change
700.93%
Ranking
Category
Stock Price
$1.90
ChartMarket Cap Chart
Since the IPO on June 18, 2021, Century Therapeutics's market cap has decreased from $1.05B to $351.29M, a decrease of -66.58%. That is a compound annual growth rate of -18.89%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 351.29M | 304.43% |
| Dec 31, 2025 | 86.86M | 1.14% |
| Dec 31, 2024 | 85.88M | -56.77% |
| Dec 29, 2023 | 198.65M | -34.34% |
| Dec 30, 2022 | 302.54M | -65.09% |
| Dec 31, 2021 | 866.61M | -17.54% |
| Jun 18, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Indaptus Therapeutics | 369.08M |
| Orchestra BioMed Holdings | 367.84M |
| Rocket Pharmaceuticals | 367.74M |
| EyePoint | 364.68M |
| Compass Therapeutics | 360.18M |
| Palisade Bio | 359.00M |
| Sionna Therapeutics | 354.92M |
| DiaMedica Therapeutics | 348.90M |